Member access

4-Traders Homepage  >  Shares  >  Nyse  >  West Pharmaceutical Services Inc.    WST   US9553061055

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
West Pharmaceutical Servic : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales1 1051 1921 2661 3751 476-
Operating income (EBITDA)178193219242266-
Operating profit (EBIT)105118142159182-
Pre-Tax Profit (EBT)-92,7109---
Net income65,375,580,7114133-
EPS ( $)1,892,162,303,233,75-
Dividend per Share ( $)0,650,69----
Yield0,95%1,01%----
Announcement Date02/17/2011
12:00pm
02/16/2012
12:00pm
02/21/2013
12:15pm
---
Finances - Leverage
West Pharmaceutical Servic : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt248258----
Finance------
Operating income (EBITDA)178193219242266-
Leverage
(Debt/EBITDA)
1,39x1,33x----
Capital Expenditure10595,4----
Book Value Per Share (BVPS)18,2 $-----
Cash Flow per Share3,77 $-----
Announcement Date02/17/2011
12:00pm
02/16/2012
12:00pm
02/21/2013
12:15pm
---
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 2 366 M$ -
Company Value - 2 366 M$
Valuation 2013e 2014e
PER (Price / EPS) 21,2x 18,2x
Capitalization / Revenue 1,72x 1,60x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 11,6% 12,3%
operating laverage (Delta EBIT / Delta Sales) 1,41x 1,97x
Net Margin (Net Profit / Revenue) 8,28% 8,99%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend
West Pharmaceutical Servic : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.